Need a Bunion Removed?

Aug 5, 2011Clinical Trial

JBR Clinical Research will soon be conducting a clinical research trial for an investigational pain medication given after Bunion Surgery. Qualified male and female participants eighteen and older may receive no cost bunion surgery and compensation for time and travel. To complete a preliminary visit to see if you may qualify for future bunion studies, visit our website at jbrclinicalresearch.com or call (801) 261-2000

JeanBrownResearch.com is a Salt Lake City based trial research organization, specializing in pain management studies, among other types of clinical trials. Follow us on Twitter and Facebook.

Update on COVID-19

To: Our Sponsors, CROs, Patients, and Employees

At CenExel Clinical Research, our top priorities are the safety and health of our patients and employees. For our Centers of Excellence to provide the highest quality of clinical research, we established and maintain a COVID-19 Task Force with representatives from every Center. The Task Force is charged with continuous monitoring of the pandemic and providing guidance and communication.

Our clinical operations continue, and we have implemented the following additional safety measures:

Enhanced screening of everyone entering any of our facilities before they are admitted into our offices or clinical areas
Reinforced internal communication regarding the COVID-19 situation, CDC and SHRM recommendations, digital team meetings, and the importance of using sick leave for anyone who has signs, symptoms, or recent exposure to someone with suspected or diagnosed COVID-19
Additional cleaning and disinfecting materials provided through our clinic and office areas
Cross-training and preparations for contingency plans if key staff need to stay home

We will continue to monitor the current situation, coordinate with the proper authorities, and update our policies and procedures as needed to ensure the safety of our patients and employees.

Need a Bunion Removed?

Share This Resource

​Update on COVID-19

To: Our Sponsors, CROs, Patients, and Employees

Update on COVID-19